RFC1 shows a lower affinity for folates as compared with HCP1/PCFT, but can compensate for HCP1/PCFT loss in HFM patients treated with high doses of folates (Qiu et al., 2006; Zhao et al., 2007). Here, SLC46A1 is linked to craniofacial microsomia.